Related Experiment Videos
Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia.
Biological Psychiatry
|January 1, 1984
Summary
Dexamethasone did not prevent memory loss from electroconvulsive therapy (ECT). Instead, it worsened attention and short-term memory in patients with major depressive disorder, particularly those receiving bilateral ECT.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Electroconvulsive therapy (ECT) is a treatment for severe depression.
- Cognitive side effects, including memory deficits, are common with ECT.
- Dexamethasone is a corticosteroid that has been investigated for its potential to mitigate ECT-induced side effects.
Purpose of the Study:
- To investigate the efficacy of dexamethasone in preventing cognitive impairment associated with electroconvulsive therapy (ECT).
- To assess the impact of dexamethasone on attention and memory in patients undergoing ECT for major depressive disorder.
- To evaluate the effect of dexamethasone on depressive symptom improvement in conjunction with bilateral versus unilateral ECT.
Main Methods:
- A double-blind, placebo-controlled study involving 48 patients diagnosed with major depressive disorder.
- Patients received either dexamethasone or placebo prior to ECT.
- Cognitive functions (attention, short-term memory) and depression severity (Hamilton Depression Scale) were assessed.
Main Results:
- Dexamethasone failed to prevent memory deficiencies typically seen after ECT.
- Dexamethasone administration was associated with significant attention (p < 0.02) and short-term memory (p < 0.0003) impairments in both bilateral and unilateral ECT groups.
- Patients receiving bilateral ECT plus dexamethasone showed significantly less depressive symptom improvement (p < 0.05) compared to those receiving bilateral ECT plus placebo.
- No significant differences in depression improvement were observed between dexamethasone and placebo groups for unilateral ECT.
Conclusions:
- Dexamethasone does not prevent ECT-induced cognitive deficits and may exacerbate attention and memory problems.
- Dexamethasone may reduce the antidepressant efficacy of bilateral ECT.
- The findings suggest that dexamethasone is not beneficial and potentially detrimental when used with ECT for major depressive disorder.